Clinical Trials Browser

Colonic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

NCT06122610 2026-01-15

Using Novel Imaging to More Safely Treat Neuroendocrine Tumors

Phase 1 Recruiting

10 enrolled

EndocrineNET

Neuroendocrine Tumors

NCT03647358 2025-12-02

Lesion Dosimetry With Iodine-124 in Metastatic Thyroid Carcinoma

Phase 1 Recruiting

60 enrolled

Head & Neck

Thyroid Neoplasms

NCT07243873 2025-11-24

Synthetic PET From CT Improves Precision Diagnosis and Treatment of Lung Cancer: a Prospective, Observational, Multicenter Study

Recruiting

10,000 enrolled

Thoracic

Lung Neoplasms

NCT06062745 2025-11-05

Pilot Study for Detection of PSMA-Low CRPC-NE Tumors With Fluciclovine PET/CT

Phase 1 Recruiting

30 enrolled

Genitourinary

Prostatic Neoplasms

NCT06566209 2025-10-15

FDG-PET as an Imaging Modality to Diagnose and Risk Stratify Subclinical, Imaging Negative Ici-Myocarditis

Recruiting

30 enrolled

Other hematologic neoplasm

Myocarditis, Hematologic Neoplasms

NCT06055790 2025-09-03

Feasibility of 18F-Fluciclovine PET/CT to Identify Brain Metastasis

Phase 2 Recruiting

20 enrolled

CNS

Brain Neoplasms

NCT04468841 2025-08-19

Measuring Cell-Free DNA (cfDNA) Levels in People With Follicular Lymphoma

Phase 1 Recruiting

100 enrolled

Lymphoid

Lymphoma, Follicular

NCT06863233 2025-08-12

A Study of CD8+ T Cell Imaging During Treatment in People With Non-Small Cell Lung Cancer

Phase 1 Recruiting

5 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT04518748 2025-08-05

Combined Y-90 Selective Internal Radiation Therapy (Y-90 SIRT) and Stereotactic Body Radiation Therapy (SBRT) in Hepatic Malignancy.

Phase 1 Recruiting

70 enrolled

Liver Malignancy

NCT05034146 2025-06-05

68Ga-FAPI PET/CT in Malignant Tumors

Phase NA Recruiting

500 enrolled

Tumor-Agnostic

Neoplasms

NCT05030597 2025-05-28

FAPI-OSCC

Recruiting

100 enrolled

Head & Neck

Mouth Neoplasms

NCT05835570 2025-04-30

Integrin αvβ6-targeted PET in Malignant Tumors

Recruiting

200 enrolled

BreastThoracic

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Neoplasm Metastasis, Neoplasms

NCT06067503 2025-04-22

Biomarkers to Detect Endocrine Therapy Resistance

Phase 2 Recruiting

8 enrolled

Breast

Breast Neoplasms, Neoplastic Cells, Circulating, Neoplasm Metastasis, Carcinoma, Lobular

NCT05172310 2021-12-29

PET Imaging of Solid Tumors by a Novel Tracer, 68Ga-FAPI

Phase 1 Recruiting

410 enrolled

GastrointestinalGynecologic

Carcinoma, Ovarian Epithelial, Bile Duct Neoplasms, Pancreatic Neoplasms, Stomach Neoplasms

Clinical Trials

Biopsy After Radioembolization to Identify Changes in Tumor Cells From the Radiation

Using Novel Imaging to More Safely Treat Neuroendocrine Tumors

Lesion Dosimetry With Iodine-124 in Metastatic Thyroid Carcinoma

Synthetic PET From CT Improves Precision Diagnosis and Treatment of Lung Cancer: a Prospective, Observational, Multicenter Study

Pilot Study for Detection of PSMA-Low CRPC-NE Tumors With Fluciclovine PET/CT

FDG-PET as an Imaging Modality to Diagnose and Risk Stratify Subclinical, Imaging Negative Ici-Myocarditis

Feasibility of 18F-Fluciclovine PET/CT to Identify Brain Metastasis

Measuring Cell-Free DNA (cfDNA) Levels in People With Follicular Lymphoma

A Study of CD8+ T Cell Imaging During Treatment in People With Non-Small Cell Lung Cancer

Combined Y-90 Selective Internal Radiation Therapy (Y-90 SIRT) and Stereotactic Body Radiation Therapy (SBRT) in Hepatic Malignancy.

68Ga-FAPI PET/CT in Malignant Tumors

FAPI-OSCC

Integrin αvβ6-targeted PET in Malignant Tumors

Biomarkers to Detect Endocrine Therapy Resistance

PET Imaging of Solid Tumors by a Novel Tracer, 68Ga-FAPI